Risk Stratification for Lung Adenocarcinoma on EGFR and TP53 Mutation Status, Chemotherapy and PD-L1 Immunotherapy

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/76390

Title:	Risk Stratification for Lung Adenocarcinoma on EGFR and TP53 Mutation Status, Chemotherapy and PD-L1 Immunotherapy
Authors:	Wu, CH Hwang, MJ
Issue Date:	2019-10
Relation:	CANCER MEDICINE 8(13), 5850-5861
URI:	http://ir.sinica.edu.tw/handle/201000000A/76390
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=2045-7634&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	https://doi.org/10.1002/cam4.2492
Appears in Collections:	生物醫學科學研究所

Show full item record

Last Week
0

Last month
0

checked on Jan 4, 2023

Check